Dr. Alfred Bach resigns as CEO of SYGNIS Pharma AG
SYGNIS Pharma AG announced that the management contract of Dr. Alfred Bach, which is going to expire at the end of the calendar-year, will not be extended upon Dr. Bach’s request. By mutual consent with the Supervisory Board Dr. Bach will resign as CEO of SYGNIS Pharma AG on the end of 28 October 2010.
The Supervisory Board thanks Dr. Bach for his commitment and efforts during the past years for SYGNIS Pharma AG. Peter Willinger, Chief Financial Officer, and, Dr. Frank Rathgeb, Chief Medical Officer, will jointly lead the Company.
Organizations
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.